Aura Biosciences, Inc.

AURA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$31,693$41,063$121,582$149,063
Short-Term Investments$119,401$185,087$67,229$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$9,529$5,644$7,891$4,641
Total Curr. Assets$160,623$231,794$196,702$153,704
Property Plant & Equip (Net)$20,594$22,004$26,042$6,201
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$768$0
Tax Assets$0$0$0$0
Other NC Assets$1,286$1,277$423$125
Total NC Assets$21,880$23,281$27,233$6,326
Other Assets$0$0$0$0
Total Assets$182,503$255,075$223,935$160,030
Liabilities
Payables$2,304$1,787$2,921$2,401
Short-Term Debt$3,149$2,687$2,963$615
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$9,460$7,883$4,573$4,339
Total Curr. Liab.$14,913$12,357$10,457$7,355
LT Debt$15,620$16,870$17,895$360
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$15,620$16,870$17,895$360
Other Liabilities$0$0$0$0
Cap. Leases$18,769$19,557$20,858$975
Total Liabilities$30,533$29,227$28,352$7,715
Equity
Pref Stock$0$0$0$0
Common Stock$0$0$0$0
Retained Earnings-$374,227-$287,308-$210,900-$152,137
AOCI$263$539-$72$0
Other Equity$525,934$512,617$406,555$304,452
Total Equity$151,970$225,848$195,583$152,315
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$182,503$255,075$223,935$160,030
Net Debt-$12,924-$21,506-$100,724-$148,088